Featured by Newsweek & World Class Media Outlets
Jason R. Povio

Jason R. Povio

President & CEO
Eagle Telemedicine
31 August 2026

Eagle Telemedicine is a physician-led, professionally managed virtual specialty access platform serving hospitals and health systems. Founded in 2008, Eagle has launched 1000 clinical programs supporting inpatient and outpatient care across more than 20 specialties, with a network of 500 physicians. Eagle assigns dedicated physician teams that work inside each hospital’s existing clinical workflow and technology.

Eagle now provides virtual physician coverage across more than 20 specialties. How did the company evolve from its original hospital-medicine program into that broader platform?

Eagle has provided virtual physician specialty care since 2008, growing to more than 20 specialties, from stroke and intensive care to endocrinology and psychiatry. Every specialty is a fully staffed, actively delivered service line, divided roughly evenly between acute and routine care.

The company began in Bardstown, Kentucky, providing nighttime hospital-medicine support. We are still there today, 18 years later, supporting that same hospital. Some of the physicians who launched the original program are still with Eagle and still caring for patients in Bardstown. That is what partnership looks like. Hospital medicine remains foundational because facilities need physicians to admit and discharge patients. Other major specialties include stroke, critical care, nephrology, gastroenterology, infectious disease and cardiology. Cardiology is especially underserved: hospitals often do not realize how many patients they transfer for chest-pain rule-outs and other essential care that could be managed locally.

Eagle assigns dedicated physician teams to individual hospital programs rather than relying on a purely on-demand model. What difference does that make to continuity of care?

There are generally two virtual-care models: what the market calls the “Uber model,” and the dedicated-pod model. Eagle assigns a group of physicians to each engagement. The physician you call at seven in the morning is the same physician you are speaking with at five in the afternoon, creating continuity around the patient.

We schedule those physicians across multiple days in most routine specialties. That creates continuity within and between shifts, allowing the virtual physician to drive the care plan alongside the attending rather than repeatedly handing the patient to someone new.

When a hospital introduces virtual specialty care, which operational foundations need to be in place before the model can function effectively at scale?

The starting point is workflow. We ask, “How do you do it today?” Introducing a virtual physician does not transform the entire care process. If the physician would ordinarily be in the room, imagine a cart there instead. Order sets, documentation templates and specialty-specific communication must support that workflow. Our physicians document directly in the hospital’s existing electronic medical record; there is no bolt-on system. We are technology-agnostic and use the existing cart and software.

The greater obstacle is the disconnect between executives who approve virtual care and the staff expected to deliver it. Teams may simply be told, “Here is Eagle Telemedicine; implement it.” We create an educational on-ramp and work through the “stay-go criteria”: can this patient remain here, or do they need an institution with the necessary wraparound services? Those discussions align everyone around the program’s purpose. Implementation is not a straight line; there are many curving roads.

Telemedicine is still often associated with low-acuity outpatient care. Why does Eagle regard the acute inpatient setting as one of its most natural applications?

In many respects, acute care is easier to provide virtually than ambulatory care. Outpatient medicine depends more heavily on longitudinal relationships; in the hospital, we treat a defined acute episode with more clinical support around it. For our first 11 years, we worked exclusively in inpatient care. We expanded into ambulatory care because patients were being discharged then returning to the emergency department without proper follow-up.

The long-term model is hybrid, not “telemedicine or no telemedicine.” My father has Parkinson’s and has received some care virtually effectively, although other elements must remain in person. An infectious-disease patient on a 30-day antibiotic course may need laboratory monitoring and virtual adjustments rather than repeated visits. In oncology, virtual follow-up after diagnosis and treatment planning can release capacity so new patients are seen sooner. Hospital-at-home programs make the same point: providing the physician is often the easiest part; arranging vascular access, diet and nursing support is much harder. The question is which modality suits each episode of care.

The Rural Care Alliance aggregates demand across independent hospitals that could not necessarily sustain specialist coverage alone. What has Eagle learned from trying to make that model financially viable?

The idea came from another industry’s friends and family plan: if friends or family joined together, everyone paid less. We asked whether independent hospitals with a shared need could behave the same way. Facilities in the same region often serve populations with similar chronic diseases, age profiles and geographic challenges. Aggregate that demand and you can create enough critical mass to justify specialty coverage, with each hospital paying a fractional share of what it would cost alone.

The concept makes obvious sense; execution is harder. Hospitals may have different technologies, contracts, legal requirements and economic priorities. It is an informal alliance rather than a common ownership structure, so annual budget decisions can affect participation. But it works. In the Great Plains region, eight hospitals participate in a shared alliance covering endocrinology and rheumatology, two specialties none of them could sustain on their own. It remains harder to execute than to describe, but the model delivers.

Virtual urology was added after an existing client approached Eagle with an unmet need. How does the company determine whether a new specialty can be delivered effectively through a virtual model?

Usually, somebody calls. I would love to say we mapped this out on a whiteboard years in advance, but most of our growth started with a client calling us with a problem to solve. We first determine what can and cannot be done virtually. Urology, gastroenterology and neurology all contain procedural work that cannot yet be delivered remotely. We then ask whether the service will improve quality, reduce cost or support revenue growth.

If the case is sound, we recruit clinicians, develop workflows and build the service with the institution. Clients have shown a willingness to work with us to build a new service line rather than continue calling around. Of our more than 20 specialties, every one except palliative care was created in response to a client request. Palliative care was the one we proactively brought to market because I believe palliative physicians do extraordinary work.

When virtual specialists allow a hospital to retain patients who would otherwise be transferred, what evidence demonstrates that the service is creating meaningful value?

There are qualitative and quantitative measures. Clinically, the question is whether patients can receive appropriate care locally. Being placed in an ambulance and sent two or three hours away creates stress. Families may be unable to take time off, visit or provide the support that helps a patient recover. Patient satisfaction can be measured through tools such as HCAHPS, but the human effect should not be underestimated.

Economically, retaining patients can preserve revenue, although the calculation differs across DSH, cost-plus and DRG-based payment models. It also helps cover fixed costs. If a hospital is already staffed for a level of activity, retained patients support that infrastructure, while incremental revenue should cover variable costs. The return should be judged through clinical outcomes, community access and the institution’s long-term sustainability.